{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:08:35Z","timestamp":1790698115991,"version":"4.1.0"},"reference-count":42,"publisher":"Japanese Circulation Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1253\/circj.cj-14-1323","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T22:45:20Z","timestamp":1426718720000},"page":"1349-1356","source":"Crossref","is-referenced-by-count":42,"title":["Circulating Platelet-Neutrophil Aggregates Play a Significant Role in Kawasaki Disease"],"prefix":"10.1253","volume":"79","author":[{"given":"Kentaro","family":"Ueno","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kagoshima Medical Association Hospital"},{"name":"Department of Pediatrics, Kagoshima City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Eguchi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiminori","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kagoshima Medical Association Hospital"},{"name":"Department of Pediatrics, Kagoshima City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneus lymph node syndrome (MLNS) prevailing in Japan. <i>Pediatrics<\/i> 1974; 54: 271\u2013276.","DOI":"10.1542\/peds.54.3.271"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kato H, Koike S, Yamamoto M, Ito Y, Yano E. Coronary aneurysms in infants and young children with acute febrile mucocutaneus lymph node syndrome. <i>J Pediatr<\/i> 1975; 86: 892\u2013898.","DOI":"10.1016\/S0022-3476(75)80220-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. <i>N Engl J Med<\/i> 1986; 315: 341\u2013347.","DOI":"10.1056\/NEJM198608073150601"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. <i>Pediatrics<\/i> 2000; 105: E78, doi:10.1542\/peds.105.6.e78.","DOI":"10.1542\/peds.105.6.e78"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, et al; RAISE study group investigators. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): A randomised, open-label, blinded-endpoints trial. <i>Lancet<\/i> 2012; 379: 1613\u20131620.","DOI":"10.1016\/S0140-6736(11)61930-2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shi G, Morrell CN. Platelets as initiators and mediators of inflammation at the vessel wall. <i>Thromb Res<\/i> 2011; 127: 387\u2013390.","DOI":"10.1016\/j.thromres.2010.10.019"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yamamoto T, Chikugo T, Tanaka Y. Elevated plasma levels of beta-thromboglobulin and platelet factor 4 in patients with rheumatic disorders and cutaneous vasculitis. <i>Clin Rheumatol<\/i> 2002; 21: 501\u2013504.","DOI":"10.1007\/s100670200123"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wagner DD, Burger PC. Platelets in inflammation and thrombosis. <i>Arterioscler Thromb Vasc Biol<\/i> 2003; 23: 2131\u20132137.","DOI":"10.1161\/01.ATV.0000095974.95122.EC"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Von Hundelshausen P, Weber C. Platelets as immune cells: Bridging inflammation and cardiovascular disease. <i>Circ Res<\/i> 2007; 100: 27\u201340.","DOI":"10.1161\/01.RES.0000252802.25497.b7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tuttle HA, Davis-Gorman G, Goldman S, Copeland JG, McDonagh PF. Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease. <i>Cardiovasc Diabetol<\/i> 2003; 2: 2\u201312.","DOI":"10.1186\/1475-2840-2-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gawaz M, Reininger A, Neumann FJ. Platelet function and platelet-leukocyte adhesion in symptomatic coronary heart disease: Effects of intravenous magnesium. <i>Thromb Res<\/i> 1996; 83: 341\u2013349.","DOI":"10.1016\/0049-3848(96)00144-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lefer AM, Campbell B, Scalia R, Lefer DJ. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: Role of selectins. <i><\/i> 1998; 98: 1322\u20131328.","DOI":"10.1161\/01.CIR.98.13.1322"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Polanowska-Grabowska R, Wallance K, Field JJ, Chen L, Marshall MA, Figler R, et al. P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease. <i>Arterioscler Thromb Vasc Biol<\/i> 2010; 30: 2392\u20132399.","DOI":"10.1161\/ATVBAHA.110.211615"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Levin M, Holland PC, Nokes TJ, Novelli V, Mola M, Levinsky RJ, et al. Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis. <i>Br Med J<\/i> 1985; 290: 1456\u20131460.","DOI":"10.1136\/bmj.290.6480.1456"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yahata T, Suzuki C, Yoshioka A, Hamaoka A, Ikeda K. Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease. <i>Circ J<\/i> 2013; 78: 188\u2013193.","DOI":"10.1253\/circj.CJ-12-1037"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ueno K, Nomura Y, Hashiguchi T, Masuda K, Morita Y, Hazeki D, et al. Platelet vascular endothelial growth factor is a useful predictor for prognosis in Kawasaki syndrome. <i>Br J Haematol<\/i> 2010; 148: 85\u201392.","DOI":"10.1111\/j.1365-2141.2009.07922.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kobayashi T, Kimura H, Okada Y, Inoue Y, Kobayashi T, Shinohara M, et al. Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease. <i>Clin Exp Immunol<\/i> 2007; 148: 112\u2013118.","DOI":"10.1111\/j.1365-2249.2007.03326.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Singbartl K, Green SA, Ley K. Blocking P-selectin protects from ischemia\/reperfusion-induced acute renal failure. <i>FASEB J<\/i> 2000; 14: 48\u201354.","DOI":"10.1096\/fasebj.14.1.48"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Zarbock A, Singbartl K, Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. <i>J Clin Invest<\/i> 2006; 116: 3211\u20133219.","DOI":"10.1172\/JCI29499"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: Linking hemostasis and inflammation. <i>Blood Rev<\/i> 2007; 21: 99\u2013111.","DOI":"10.1016\/j.blre.2006.06.001"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Liverani E, Banerjee S, Roberts W, Naseem KM, Perretti M. Prednisolone exerts exquisite inhibitory properties on platelet functions. <i>Biochem Pharmacol<\/i> 2012; 83: 1364\u20131373.","DOI":"10.1016\/j.bcp.2012.02.006"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kato H, Koike S, Yokoyama T. Kawasaki disease: Effect of treatment on coronary artery involvement. <i>Pediatrics<\/i> 1979; 63: 175\u2013179.","DOI":"10.1542\/peds.63.2.175"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapy. <i>Pediatr Int<\/i> 2001; 43: 211\u2013217.","DOI":"10.1046\/j.1442-200x.2001.01373.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al; Kawasaki Disease Research Committee. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). <i>Pediatr Int<\/i> 2005; 47: 232\u2013234.","DOI":"10.1111\/j.1442-200x.2005.02033.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013): Digest version. <i>Circ J<\/i> 2014; 78: 2521\u20132562.","DOI":"10.1253\/circj.CJ-66-0096"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. <i>Circulation<\/i> 2006; 113: 2606\u20132612.","DOI":"10.1161\/CIRCULATIONAHA.105.592865"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ogata S, Tremoulet AH, Sato Y, Ueda K, Shimizu C, Sun X, et al. Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. <i>Int J Cardiol<\/i> 2013; 168: 3825\u20133828.","DOI":"10.1016\/j.ijcard.2013.06.027"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Wang F, Wang NS, Yan CG, Li JH, Tang LQ. The significance of platelet activation in rheumatoid arthritis. <i>Clin Rheumatol<\/i> 2007; 26: 768\u2013771.","DOI":"10.1007\/s10067-007-0550-0"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Huo Y, Ley KF. Role of platelets in the development of atherosclerosis. <i>Trends Cardiovasc Med<\/i> 2004; 14: 18\u201322.","DOI":"10.1016\/j.tcm.2003.09.007"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kirschenbaum LA, Aziz M, Astiz ME, Saha DC, Rackow EC. Influence of rheologic changes and platelet-neutrophil interactions on cell filtration in sepsis. <i>Am J Respir Crit Care Med<\/i> 2000; 161: 1602\u20131607.","DOI":"10.1164\/ajrccm.161.5.9902105"},{"key":"31","unstructured":"31. Barnard MR, Krueger LA, Frelinger AL 3rd, Furman MI, Michelson AD. Whole blood analysis of leukocyte-platelet aggregates. Curr Protoc Cytom 2003; Chapter 6: Unit 6. <i>Curr Protoc Cytom<\/i> 2003; Chapter 6: Unit 6.15."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Furie B, Furie BC. Leukocyte crosstalk at the vascular wall. <i>Thromb Haemost<\/i> 1997; 78: 306\u2013309.","DOI":"10.1055\/s-0038-1657544"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Li A, Yang F, Dunn S, Gross AK, Smyth SS. Platelets as immune mediators: Their role in host defense responses and sepsis. <i>Thromb Res<\/i> 2011; 127: 184\u2013188.","DOI":"10.1016\/j.thromres.2010.10.010"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indexes of platelet activation in vivo. <i>Blood<\/i> 1981; 57: 199\u2013202.","DOI":"10.1182\/blood.V57.2.199.199"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: Immunohistochemical study. <i>Circulation<\/i> 2000; 101: 2935\u20132941.","DOI":"10.1161\/01.CIR.101.25.2935"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Nijm J, Wikby A, Tompa A, Olsson AG, Jonasson L. Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. <i>Am J Cardiol<\/i> 2005; 95: 452\u2013456.","DOI":"10.1016\/j.amjcard.2004.10.009"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. <i>Nat Med<\/i> 2003; 9: 61\u201367.","DOI":"10.1038\/nm810"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Maugeri N, Brambilla M, Camera M, Carbone A, Tremoli E, Donati MB, et al. Human polymorphonuclear leukocytes produce and express tissue factor upon stimulation. <i>J Thromb Haemost<\/i> 2006; 4: 1323\u20131330.","DOI":"10.1111\/j.1538-7836.2006.01968.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. del Conde I, Nabi F, Tonda R, Thiagarajan P, Lopez JA, Kleiman NS. Effect of P-selectin on phosphatidylserine exposure and surface dependent thrombin generation on monocytes. <i>Arterioscler Throm Vasc Biol<\/i> 2005; 25: 1065\u20131070.","DOI":"10.1161\/01.ATV.0000159094.17235.9b"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. <i>Nat Genet<\/i> 2008; 40: 35\u201342.","DOI":"10.1038\/ng.2007.59"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Moraes LA, Paul-Clark MJ, Rickman A, Flower RJ, Goulding NJ, Perretti M. Ligand-specific glucocorticoid receptor activation in human platelets. <i>Blood<\/i> 2005; 106: 4167\u20134175.","DOI":"10.1182\/blood-2005-04-1723"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Okada Y, Shinohara M, Kobayashi T, Inoue Y, Tomomasa T, Kobayashi T, et al. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. <i>J Pediatr<\/i> 2003; 143: 363\u2013367.","DOI":"10.1067\/S0022-3476(03)00387-1"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/6\/79_CJ-14-1323\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T13:01:09Z","timestamp":1651582869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/6\/79_CJ-14-1323\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-14-1323","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}